Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT02958670
NA

Imaging Tau Deposition in the Brain of Elderly Subjects

Sponsor: University of Zurich

View on ClinicalTrials.gov

Summary

Cerebral accumulation of tau and beta-amyloid are major factors of Alzheimer's disease pathology. A novel Positron Emission Tomography (PET) tracer (18-F-AV-1451) now offers the ability to study tau protein deposition in vivo in subjects, in which information on cerebral amyloid deposition has already been gathered. This enables to study effects of tau deposition on neuronal integrity, their relation to effects of beta-amyloid deposition and how this contributes to cognitive impairment or well-being in the elderly.

Key Details

Gender

All

Age Range

50 Years - Any

Study Type

INTERVENTIONAL

Enrollment

141

Start Date

2016-11

Completion Date

2029-12

Last Updated

2023-11-09

Healthy Volunteers

Yes

Interventions

OTHER

18F-AV-1451 (Tau-PET tracer)

Single i.v. administration of 18F-AV-1451 (Tau-PET tracer) and consecutive Positron-Emission-Tomography-Scan

Locations (1)

Institute for Regenerative Medicine (IREM)

Schlieren, Canton of Zurich, Switzerland